SWEDISH ORPHAN BIOVITRUM A/S
CVR 19179079 · Public limited company (A/S) · Active · Low risk
SWEDISH ORPHAN BIOVITRUM A/S is a Public limited company (A/S), founded on , based in Kgs.Lyngby. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 39.5m and a net result of DKK 3.3m. CEO: Bjørn Gustaf Östen Berglund.
Bankruptcy risk for SWEDISH ORPHAN BIOVITRUM A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 19179079
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (30 years)
- Address
- Sorgenfrivej 17
2800 Kgs.Lyngby - Municipality
- Lyngby-Taarbæk
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 500k
- Employees
- 15 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 29 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 89.6% |
| Current ratio | 958% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 11 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 18.0m | DKK 20.7m |
| Net profit | DKK 3.3m | DKK 4.6m |
| Equity | DKK 39.5m | DKK 36.2m |
| Total assets | DKK 44.1m | DKK 40.7m |
| Cash | DKK 2.9m | – |
| Short-term debt | DKK 4.6m | – |
| Tax owed | DKK 552k | – |
| Avg. employees | 8 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring om udvidet gennemgang · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 160 | ||
| 1 Jan 2024 – 31 Dec 2024 | 185 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 177 | ||
| 1 Jan 2022 – 31 Dec 2022 | 172 | ||
| 1 Jan 2021 – 31 Dec 2021 | 180 | ||
| 1 Jan 2020 – 31 Dec 2020 | 174 | ||
| 1 Jan 2019 – 31 Dec 2019 | 150 | ||
| 1 Jan 2018 – 31 Dec 2018 | 144 | ||
| 1 Jan 2017 – 31 Dec 2017 | 150 | ||
| 1 Jan 2016 – 31 Dec 2016 | 149 | ||
| 1 Jan 2015 – 31 Dec 2015 | 148 | ||
| 1 Jan 2014 – 31 Dec 2014 | 141 | ||
| 1 Jan 2013 – 31 Dec 2013 | 143 | ||
| 1 Jan 2012 – 31 Dec 2012 | 150 | ||
| 1 Jan 2011 – 31 Dec 2011 | 151 | ||
| 1 Jan 2010 – 31 Dec 2010 | 101 | ||
| 1 May 2008 – 30 Apr 2009 | 147 | ||
| 1 May 2007 – 30 Apr 2008 | 153 | ||
| 1 May 2006 – 30 Apr 2007 | 154 | ||
| 1 May 2005 – 30 Apr 2006 | 142 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Bjørn Gustaf Östen Berglund | Current | |
| CEO | Bo Jesper Hansen | ||
| CEO | Lena Storm Christensen | ||
| CEO | Ulf Blangsted Henriksen | ||
| CEO | Lisbeth Hansen | ||
| CEO | Gitte Nøhr Ludvig | ||
| Board | Bjørn Gustaf Östen Berglund | Current | |
| Board | Karl Henrik Stenqvist | Current | |
| Board | Soufiane Fahmy | Current | |
| Board | Lars Uno Larsson | ||
| Board | Hans-Erik Almbo | ||
| Board | Gunnar Wilhelm Paro | ||
| Board | Bo Jesper Hansen | ||
| Board | Lena Storm Christensen | ||
| Board | Pär Gustav Östensjö | ||
| Board | Ulf Blangsted Henriksen | ||
| Board | Lisbeth Hansen | ||
| Board | Janne Antti Laine | ||
| Board | Gitte Nøhr Ludvig | ||
| Board | Alf Gunnar Martin Nicklasson | ||
| Board | Frank Carl Kennet Rooth | ||
| Board | Per Anders Edvell | ||
| Board | Cameron Geoffrey McDonough | ||
| Board | Alan Henry Raffensperger | ||
| Board | Mats Olof Wallin | ||
| Board | Hege Hellstrøm | ||
| Board | Christian Dreger | ||
| Board | Philip Alexander Wood | ||
| Owner (100%) | Swedish Orphan Biovitrum International AB | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | VPBLTH A/S | ||
| Auditor | inforevision statsautoriseret revisionsaktieselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Swedish Orphan AB | Current |
The CEOs' other companies
Bo Jesper Hansen – 15 other companies
- ACE BIOSCIENCES ApS Fusioneret
- AZANTA A/S Active
- BJH ApS Opløst
- INNOVENTA MEDICA ApS Active
- MIPSALUS ApS Active
- MIPSALUS HOLDING ApS Active
- MoxieLab ApS Active
- NØRREGADE 10. 1993 ApS Opløst
- Reapplix A/S Active
- Strategic Partners A/S Active
- TOPOTARGET A/S Fusioneret
- VIVOSTAT A/S Active
- WITTENBERGE. 1996 ApS Opløst
- ZYMENEX ApS Fusioneret
- ZYMENEX HOLDING ApS Opløst
Lena Storm Christensen – 3 other companies
- AddStorm ApS Active
- AddStorm Holding ApS Active
- Aristo Pharma Nordic ApS Active
Ulf Blangsted Henriksen – 12 other companies
- ALTERNOVA A/S Fusioneret
- DANSK KENRAL ApS Opløst
- HC NORDIC ApS Compulsorily dissolved
- HELLE HENRIKSEN MEDICINSKE UDSTYR ApS Opløst
- MONSANTO DANMARK A/S Fusioneret
- ORGANON A/S Fusioneret
- PARANOVA DANMARK ApS Active
- PARANOVA GROUP ApS Active
- PARANOVA PACK ApS Active
- PHARMACIA & UPJOHN A/S Fusioneret
- PHARMACIA A/S Fusioneret
- SELSKABET AF 24. SEPTEMBER 2004 A/S Opløst
Lisbeth Hansen – 1 other companies
- HAV TORVEHALLERNE A/S Active
Gitte Nøhr Ludvig – 1 other companies
- AZANTA A/S Active
Address history (2 moves)
| Sorgenfrivej 17, 2800 Kgs.Lyngby | |
| Wilders Plads 5, 1403 København K | |
| c/o Bygning V, Wilders Plads, 1403 København K |
Former names
| SWEDISH ORPHAN BIOVITRUM A/S | – now |
| SWEDISH ORPHAN A/S | – |
| ORPHAN DENMARK A/S | – |
Employees per year
Other companies at the same address
- KÆRKOMMEN HOVEDSTADEN A/S Fusioneret
Similar companies in Lyngby-Taarbæk
- DENTSPLY IH A/S Kongens Lyngby
- Aceso Pharma ApS Virum
- Wellspect ApS Kongens Lyngby
- Aceso Nordic ApS Virum
- INTEGO MEDICAL ApS Virum
- GLOBE PHARMA ApS Kongens Lyngby
- DIANOVA A/S Kongens Lyngby
- BLUE SURGICAL ApS Virum
- MERIT MEDICAL DENMARK A/S Kongens Lyngby
- UNIGROUP ApS Kongens Lyngby
- CSL BEHRING ApS Kongens Lyngby
- DANAMEDIC ApS Kgs.Lyngby
Questions and answers about SWEDISH ORPHAN BIOVITRUM A/S
Has SWEDISH ORPHAN BIOVITRUM A/S gone bankrupt?
No, SWEDISH ORPHAN BIOVITRUM A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SWEDISH ORPHAN BIOVITRUM A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of SWEDISH ORPHAN BIOVITRUM A/S?
Bjørn Gustaf Östen Berglund is the CEO of SWEDISH ORPHAN BIOVITRUM A/S.
Who is the auditor of SWEDISH ORPHAN BIOVITRUM A/S?
SWEDISH ORPHAN BIOVITRUM A/S most recently used EY Godkendt Revisionspartnerselskab.
When was SWEDISH ORPHAN BIOVITRUM A/S founded?
SWEDISH ORPHAN BIOVITRUM A/S was founded on 8 February 1996.
What is the equity of SWEDISH ORPHAN BIOVITRUM A/S?
Equity was DKK 39.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.